Literature DB >> 27613256

RETRACTED: Low density lipoprotein receptor targeted doxorubicin/DNA-Gold Nanorods as a chemo- and thermo-dual therapy for prostate cancer.

Nan Zhang1, Shasha Li1, Haiying Hua2, Dan Liu2, Lili Song1, Pengchao Sun1, Weiwei Huang1, Yafang Tang1, Yongxing Zhao3.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the authors and sanctioned by the Editor-in-Chief. The authors found errors in the data presentation - apoptotic statistics and in vivo distribution - which makes the conclusion not representative. The authors express sincere apologies for the error and inconvenience to readers.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Doxorubicin; Gold nanorods; Low density lipoprotein peptide; Prostate cancer; Thermotherapy

Mesh:

Substances:

Year:  2016        PMID: 27613256     DOI: 10.1016/j.ijpharm.2016.09.002

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor.

Authors:  Jia Gu; Neng Zhu; Hong-Fang Li; Tan-Jun Zhao; Chan-Juan Zhang; Duan-Fang Liao; Li Qin
Journal:  Cell Oncol (Dordr)       Date:  2022-07-22       Impact factor: 7.051

2.  Improving Cell Penetration of Gold Nanorods by Using an Amphipathic Arginine Rich Peptide.

Authors:  Ana L Riveros; Cynthia Eggeling; Sebastián Riquelme; Carolina Adura; Carmen López-Iglesias; Fanny Guzmán; Eyleen Araya; Mario Almada; Josué Juárez; Miguel A Valdez; Ignacio A Fuentevilla; Olga López; Marcelo J Kogan
Journal:  Int J Nanomedicine       Date:  2020-03-17

3.  Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy.

Authors:  Haiying Hua; Nan Zhang; Dan Liu; Lili Song; Tuanbing Liu; Shasha Li; Yongxing Zhao
Journal:  Int J Nanomedicine       Date:  2017-10-25

4.  Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells.

Authors:  Sylwia Michlewska; Maksim Ionov; Aleksandra Szwed; Aneta Rogalska; Natalia Sanz Del Olmo; Paula Ortega; Marta Denel; Damian Jacenik; Dzmitry Shcharbin; Francisco Javier de la Mata; Maria Bryszewska
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

5.  Construction and application of a liver cancer-targeting drug delivery system based on core-shell gold nanocages.

Authors:  Mengfei Ji; Xiaojing Qiu; Lin Hou; Shengnan Huang; Yuanmin Li; Yang Liu; Shaofeng Duan; Yurong Hu
Journal:  Int J Nanomedicine       Date:  2018-03-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.